date,title,source
Oct-30-18,3 Healthcare Stocks that Could Move on Industry Growth,ACCESSWIRE
Oct-30-18,Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation,PR Newswire
Oct-31-18,"Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018",PR Newswire
Nov-07-18,Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update,PR Newswire
Nov-28-18,5 Top-Ranked Rising P/E Stocks to Lure Investors,Zacks
Nov-29-18,"Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals",Zacks
Dec-18-18,Achieve Announces Update on Cytisinicline Clinical Development Program,PR Newswire
Dec-28-18,5 Top Rising P/E Stocks to Enjoy Solid Gains,Zacks
Feb-20-19,Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation,PR Newswire
Feb-22-19,Four Healthcare Stocks Looking to Close Out a Strong Week,ACCESSWIRE
Feb-22-19,Achieve Life Sciences' stock rockets on heavy volume after update results of smoking-cessation drug trial,MarketWatch
Feb-22-19,"Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting",PR Newswire
Feb-25-19,Healthcare Stocks Leading the Sector,ACCESSWIRE
Feb-25-19,"Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful?",Simply Wall St.
Feb-28-19,Predictive Technology Group Names Jay M. Moyes to Its Board of Directors,GlobeNewswire
Mar-05-19,"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019",PR Newswire
Mar-12-19,ACHV: A Reason to Quit is a Reason to Buy,Zacks Small Cap Research
Mar-14-19,Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update,PR Newswire
Mar-15-19,Four Healthcare Stocks Picking Up Speed On Friday,ACCESSWIRE
Mar-18-19,What Do the Clinical Updates at Achieve Life Sciences Mean for Cytisinicline,ACCESSWIRE
Mar-18-19,"Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019",PR Newswire
Mar-25-19,ACHV: Fiscal Year 2018 Operational and Financial Results,Zacks Small Cap Research
Apr-02-19,"The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",Benzinga
Apr-02-19,Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation,PR Newswire
Apr-03-19,"Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019",PR Newswire
Apr-24-19,"Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation",PR Newswire
Apr-26-19,"ACHV: Final Enrollee, Final Visit",Zacks Small Cap Research
May-07-19,"Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019",PR Newswire
